+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Regenerative Medicine Global Market Opportunities And Strategies To 2031

  • PDF Icon

    Report

  • 416 Pages
  • July 2022
  • Region: Global
  • The Business Research Company
  • ID: 5633474
This report describes and explains the global regenerative medicine market and covers 2016 to 2021, termed the historic period, and 2021 to 2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The global regenerative medicine market reached a value of nearly $7,282.2 million in 2020, having increased at a compound annual growth rate (CAGR) of 54.1% since 2015. The market is expected to grow from $7,282.2 million in 2020 to $22,373.7 million in 2025 at a rate of 25.2%. The market is then expected to grow at a CAGR of 12.7% from 2025 and reach $40,710.1 million in 2030.

Growth in the historic period in the regenerative medicine market resulted from rising prevalence of chronic diseases, emerging markets growth, implementation of the 21st century cures act, rapid growth in aging population, and the improvement in healthcare awareness and expenditure. The market was restrained by high cost of cell and gene therapies, ethical concerns related to the use of embryonic stem cells in research and development, and inadequate reimbursements.

Going forward, rising demand for organ transplantations, growth in healthcare expenditure, technological advancements in regenerative medicines, rising investments in regenerative medicine research, and changes in lifestyles. Factors that could hinder the growth of the market in the future include rising popularity of alternative therapies and natural remedies, low per capita healthcare expenditure, and tissue-engineered products and biomaterials are lagging in adoption.

The regenerative medicine market is segmented by product into cell based, gene based and tissue based. The tissue based segment was the largest segment of the regenerative medicine market segmented by product, accounting for 74.4% of the total in 2020. Going forward, the gene based segment is expected to be the fastest growing segment in the regenerative medicine market segmented by product, at a CAGR of 30.8% during 2020-2025.

The regenerative medicine market is also segmented by end-use into ambulatory surgical centers, hospitals and clinics, and others. The hospitals and clinics segment was the largest segment of the regenerative medicine market segmented by end-use, accounting for 63.8% of the total in 202o. Going forward, hospitals and clinics segment is expected to be the fastest growing segment in the regenerative medicine market segmented by end-use, at a CAGR of 25.3% during 2020-2025.

The regenerative medicine market is also segmented by application into musculoskeletal, oncology, dental, wound care and others. The oncology segment was the largest segment of the regenerative medicine market segmented by application, accounting for 60.0% of the total in 2020. Going forward, musculoskeletal segment is expected to be the fastest growing segment in the regenerative medicine market segmented by application, at a CAGR of 27.4% during 2020-2025.

North America was the largest region in the regenerative medicine market, accounting for 53.3% of the total in 2020. It was followed by the Western Europe, Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the regenerative medicine market will be Middle East and South America where growth will be at CAGRs of 72.4% and 71.9% respectively during 2020-2025. These will be followed by Eastern Europe and Asia Pacific, where the markets are expected to register CAGRs of 57.8% and 49.7% respectively during 2020-2025.

The disease is highly infectious and contagious in nature, for which the population is not pre-immune. Hence, diagnosis plays a critical role in such diseases. The number of people infected with the COVID-19 virus has been increasing significantly which calls for the need to shorten the time taken for diagnosis and treatment, better and accurate detection speeds, and the development of innovative molecular diagnostic techniques. The availability of efficient and accurate laboratory diagnosis is critical for the effective prevention and control of the pandemic. Early detection, diagnosis, isolation, and treatment is the most effective way to prevent and control COVID 19. The COVID-19 impacted the global regenerative medicine market in the initial phase pandemic. Elective surgeries were cancelled or postponed to reserve the available limited capacities and resources such as hospital beds and healthcare professionals toward COVID-19 patient care. Moreover, to control the rising number of positive COVID-19 cases, several countries implemented lockdowns and curfews. Furthermore, patients were unable to visit hospitals, clinics, or OPDs due to the lockdowns. The regeneration industries are projected to be hindered by the temporary denial of wound care services, cancer care surgeries/therapies, and other healthcare services.

The global regenerative medicine market is fragmented, with a large number of players. The top ten competitors in the market made up to xx% of the total market in 2020. Companies in the market are expanding their business by adopting various strategies, such as mergers and acquisitions, while others are focusing on expanding its product portfolio by launching new products with advanced technology to retain their market share. Major players in the market are Smith & Nephew plc, Integra LifeSciences, Stryker Corporation, MiMedx Group, Inc., Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, AbbVie, CONMED Corporation, Arthrex Inc., Baxter International Inc. and other players.

The top opportunities in the regenerative medicine market segmented by product will arise in tissue based segment, which will gain $11,532.7millions of global annual sales by 2025. The top opportunities in the regenerative medicine market segmented by end-use will arise in hospitals & clinics segment, which will gain $10,482.5millions of global annual sales by 2025. The top opportunities in the regenerative medicine market segmented by application will arise in oncology segment, which will gain $9,624.7 million of global annual sales by 2025. The regenerative medicine market size will gain the most in the USA at $5,031.7 million.

Market-trend-based strategies for the regenerative medicine include growing use of mesenchymal stem cell technology, increasing research and development on use of novel gene therapy techniques, advancements in technology transfer and clinical translation, rising strategic collaborations, partnerships and agreements, growth and advent of new companies, injectable hydrogel role in cartilage repair as a regenerative medicine, and global research initiatives and funding.

Player-adopted strategies in the regenerative medicine market includes strengthening its business by acquiring companies with same business, focus on research and development of new products and for the same is getting into partnerships and collaborations, and focusing on expanding its product portfolio by launching new products with advanced technology.

To take advantage of the opportunities, the publisher reccomends the regenerative medicine companies to focus on Mesenchymal stem cell technology, focus on strategic collaborations, partnerships and agreements, expand in emerging markets, provide competitively priced offerings in low-income countries, offer value-based pricing, participate in trade shows and events, focus on patient referral systems, target the elderly population and target hospitals and pharmacies to spread awareness.

Frequently Asked Questions about the Global Regenerative Medicine Market

What is the estimated value of the Global Regenerative Medicine Market?

The Global Regenerative Medicine Market was estimated to be valued at $7282.2 Million in 2021.

What is the growth rate of the Global Regenerative Medicine Market?

The growth rate of the Global Regenerative Medicine Market is 18.8%, with an estimated value of $40710.1 Million by 2030.

What is the forecasted size of the Global Regenerative Medicine Market?

The Global Regenerative Medicine Market is estimated to be worth $40710.1 Million by 2030.

Who are the key companies in the Global Regenerative Medicine Market?

Key companies in the Global Regenerative Medicine Market include Smith & Nephew plc, Integra LifeSciences, Stryker Corporation and Zimmer Biomet Holdings Inc..

Table of Contents

1. Regenerative Medicine Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Product
6.3. Segmentation By Application
6.4. Segmentation By End-Use
7. Regenerative Medicine Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Product
7.2.1. Cell-based
7.2.2. Gene based
7.2.3. Tissue based
7.3. Market Segmentation By End-Use
7.3.1. Ambulatory Surgical Centers
7.3.2. Hospitals And Clinics
7.3.3. Others
7.4. Market Segmentation By Application
7.4.1. Musculoskeletal
7.4.2. Oncology
7.4.3. Dental
7.4.4. Wound care
7.4.5. Others
8. Regenerative Medicine Market Trends And Strategies
8.1. Growing Use of Mesenchymal Stem Cell Technology
8.2. Increasing Research And Development On Use Of Novel Gene Therapy Techniques
8.3. Advancements In Technology Transfer And Clinical Translation
8.4. Rising Strategic Collaborations, Partnerships And Agreements
8.5. Growth And Advent Of New Companies
8.6. Injectable Hydrogel Role In Cartilage Repair As a Regenerative Medicine
8.7. Global Research Initiatives And Funding
9. Impact Of COVID-19 On Regenerative Medicine
9.1. Impact On Companies Manufacturing And Commercial Operations
9.2. Impact On Research And Development Activities
9.3. Future Outlook
10. Global Regenerative Medicine Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2015-2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015-2020
10.2.2. Restraints On The Market 2015-2020
10.3. Forecast Market Growth, 2015-2020, 2030F Value ($ Million)
10.3.1. Drivers Of The Market 2020-2025
10.3.2. Restraints On The Market 2020-2025
11. Global Regenerative Medicine Market Segmentation
11.1. Global Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.2. Global Regenerative Medicine Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.3. Global Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12. Regenerative Medicine Market, Regional And Country Analysis
12.1. Global Regenerative Medicine Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Regenerative Medicine Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13. Asia-Pacific Regenerative Medicine Market
13.1. Asia-Pacific Regenerative Medicine Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory Bodies
13.1.7. Major Associations
13.1.8. Taxes levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3. Asia-Pacific Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.4. Asia-Pacific Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.6. Asia-Pacific Regenerative Medicine Market: Country Analysis
13.7. China Regenerative Medicine Market
13.8. China Regenerative Medicine Market Overview
13.8.1. Region Information
13.8.2. Market Information
13.8.3. Background Information
13.8.4. Government Initiatives
13.8.5. Regulations
13.8.6. Regulatory Bodies
13.8.7. Major Associations
13.8.8. Taxes Levied
13.8.9. Corporate Tax Structure
13.8.10. Investments
13.8.11. Major Companies
13.9. China Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.10. China Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.11. China Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.12. China Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.13. India Regenerative Medicine Market
13.14. India Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.15. India Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.16. India Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.17. India Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.18. Japan Regenerative Medicine Market
13.19. Japan Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.20. Japan Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.21. Japan Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.22. Japan Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.23. Australia Regenerative Medicine Market
13.24. Australia Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.25. Australia Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.26. Australia Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.27. Australia Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.28. Indonesia Regenerative Medicine Market
13.29. Indonesia Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.30. Indonesia Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.31. Indonesia Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.32. South Korea Regenerative Medicine Market
13.33. South Korea Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.34. South Korea Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.35. South Korea Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.36. South Korea Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14. Western Europe Regenerative Medicine Market
14.1. Western Europe Regenerative Medicine Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory Bodies
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Regenerative Medicine Market: Country Analysis
14.3. UK Regenerative Medicine Market
14.4. UK Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.5. UK Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.6. UK Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.7. UK Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.8. Germany Regenerative Medicine Market
14.9. Germany Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.10. Germany Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.11. Germany Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.12. Germany Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.13. France Regenerative Medicine Market
14.14. France Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.15. France Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.16. France Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.17. France Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.18. Austria Regenerative Medicine Market
14.19. Austria Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.20. Austria Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.21. Austria Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.22. Austria Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.23. Belgium Regenerative Medicine Market
14.24. Belgium Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.25. Belgium Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.26. Belgium Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.27. Belgium Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.28. Denmark Regenerative Medicine Market
14.29. Denmark Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.30. Denmark Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.31. Denmark Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.32. Denmark Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.33. Finland Regenerative Medicine Market
14.34. Finland Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.35. Finland Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.36. Finland Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.37. Finland Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.38. Ireland Regenerative Medicine Market
14.39. Ireland Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.40. Ireland Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.41. Ireland Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.42. Ireland Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.43. Italy Regenerative Medicine Market
14.44. Italy Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.45. Italy Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.46. Italy Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.47. Italy Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.48. Netherlands Regenerative Medicine Market
14.49. Netherlands Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.50. Netherlands Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.51. Netherlands Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.52. Netherlands Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.53. Norway Regenerative Medicine Market
14.54. Norway Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.55. Norway Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.56. Norway Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.57. Norway Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.58. Portugal Regenerative Medicine Market
14.59. Portugal Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.60. Portugal Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.61. Portugal Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.62. Portugal Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.63. Spain Regenerative Medicine Market
14.64. Spain Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.65. Spain Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.66. Spain Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.67. Spain Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.68. Sweden Regenerative Medicine Market
14.69. Sweden Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.70. Sweden Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.71. Sweden Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.72. Sweden Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.73. Switzerland Regenerative Medicine Market
14.74. Switzerland Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.75. Switzerland Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.76. Switzerland Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.77. Switzerland Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15. Eastern Europe Regenerative Medicine Market
15.1. Eastern Europe Regenerative Medicine Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulations
15.1.6. Regulatory Bodies
15.1.7. Major Associations
15.1.8. Taxes Levied
15.1.9. Corporate Tax Structure
15.1.10. Investments
15.1.11. Major Companies
15.2. Eastern Europe Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.3. Eastern Europe Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.4. Eastern Europe Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Regenerative Medicine Market: Country Analysis
15.7. Russia Regenerative Medicine Market
15.8. Russia Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.9. Russia Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.10. Russia Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.11. Russia Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.12. Czech Republic Regenerative Medicine Market
15.13. Czech Republic Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.14. Czech Republic Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.15. Czech Republic Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.16. Poland Regenerative Medicine Market
15.17. Poland Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.18. Poland Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.19. Poland Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.20. Poland Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.21. Romania Regenerative Medicine Market
15.22. Romania Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.23. Romania Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.24. Romania Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.25. Romania Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16. North America Regenerative Medicine Market
16.1. North America Regenerative Medicine Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulations
16.1.6. Regulatory Bodies
16.1.7. Major Associations
16.1.8. Taxes Levied
16.1.9. Corporate Tax Structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.3. North America Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.4. North America Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Regenerative Medicine Market: Country Analysis
16.7. USA Regenerative Medicine Market
16.8. USA Regenerative Medicine Market Overview
16.8.1. Region Information
16.8.2. Market Information
16.8.3. Background Information
16.8.4. Government Initiatives
16.8.5. Regulations
16.8.6. Regulatory Bodies
16.8.7. Major Associations
16.8.8. Taxes Levied
16.8.9. Corporate Tax Structure
16.8.10. Investments
16.8.11. Major Companies
16.9. USA Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.10. USA Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.11. USA Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.13. Canada Regenerative Medicine Market
16.14. Canada Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.15. Canada Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.16. Canada Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.17. Canada Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.18. Mexico Regenerative Medicine Market
16.19. Mexico Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.20. Mexico Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.21. Mexico Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.22. Mexico Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17. South America Regenerative Medicine Market
17.1. South America Regenerative Medicine Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.3. South America Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.4. South America Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.6. South America Regenerative Medicine Market: Country Analysis
17.7. Brazil Regenerative Medicine Market
17.8. Brazil Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.9. Brazil Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.10. Brazil Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.11. Brazil Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18. Middle East Regenerative Medicine Market
18.1. Middle East Regenerative Medicine Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Regulations
18.1.5. Regulatory Bodies
18.1.6. Major Associations
18.1.7. Taxes Levied
18.1.8. Corporate Tax Structure
18.1.9. Investments
18.1.10. Major Companies
18.2. Middle East Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.3. Middle East Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.4. Middle East Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.6. Middle East Regenerative Medicine Market: Country Analysis
18.7. Israel Regenerative Medicine Market
18.8. Israel Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.9. Israel Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.10. Israel Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.11. Israel Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.12. Saudi Arabia Regenerative Medicine Market
18.13. Saudi Arabia Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.14. Saudi Arabia Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.15. Saudi Arabia Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.16. Saudi Arabia Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.17. United Arab Emirates Regenerative Medicine Market
18.18. United Arab Emirates Regenerative Medicine Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.19. United Arab Emirates Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.20. United Arab Emirates Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.21. United Arab Emirates Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.22. Turkey Regenerative Medicine Market
18.23. Turkey Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.24. Turkey Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.25. Turkey Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19. Africa Regenerative Medicine Market
19.1. Africa Regenerative Medicine Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
19.3. Africa Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.4. Africa Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.5. Africa Regenerative Medicine Market: Country Analysis
19.6. South Africa Regenerative Medicine Market
19.7. South Africa Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
19.8. South Africa Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.9. South Africa Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.10. Egypt Regenerative Medicine Market
19.11. Egypt Regenerative Medicine Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
19.12. Egypt Regenerative Medicine Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.13. Egypt Regenerative Medicine Market, Segmentation By End-Use, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20. Regenerative Medicine Global Market Competitive Landscape
20.1. Company Profiles
20.2. Smith & Nephew plc
20.2.1. Company Overview
20.2.2. Products And Services.
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Integra LifeSciences
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Stryker Corporation
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. MiMedx Group, Inc.
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Zimmer Biomet Holdings Inc.
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview
21. Key Mergers And Acquisitions In The Regenerative Medicine Market
21.1. Cesca Therapeutics Inc. Acquired ThermoGenesis Corp
21.2. Bioventus Inc. Acquired Misonix Inc.
21.3. Sanofi Acquired Kadmon Holdings Inc.
21.4. Bioventus Inc. Acquired CartiHeal
21.5. Integra LifeSciences Acquired ACell
21.6. Orgenesis Inc. Acquires Koligo Therapeutics Inc.
21.7. Gene Techno Science Co., Ltd. Acquired Japan Regenerative Medicine Co., Ltd.
21.8. Sartorius Acquired Biological Industries
21.9. Bristol-Myers Squibb Company Acquired Celgene Corporation
21.10. Smith & Nephew Plc Acquired Osiris Therapeutics, Inc.
21.11. Astellas Pharma Inc. Acquired Universal Cells Inc.
22. Regenerative Medicine Market Opportunities And Strategies
22.1. Global Regenerative Medicine Market In 2025 - Countries Offering Most New Opportunities
22.2. Global Regenerative Medicine Market In 2025 - Segments Offering Most New Opportunities
22.3. Global Regenerative medicine Market In 2025 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies
23. Regenerative Medicine Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People
24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher
24.6. Copyright and Disclaimer

Executive Summary

Regenerative Medicine Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global regenerative medicine market as it emerges from the COVID 19 shut down.



Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors. .
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest growing market for regenerative medicine? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The regenerative medicine market global report answers all these questions and many more.


The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider regenerative medicine market; and compares it with other markets.



The report covers the following chapters

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives a brief introduction about segmentation by geography, segmentation by product, segmentation by application and segmentation by end-use.
  • Market Characteristics - The market characteristics section of the report defines and explains the regenerative medicine market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies - This chapter describes the major trends shaping the global regenerative medicine market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This section describes the impact of COVID-19 on the regenerative medicine market.
  • Global Market Size And Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa, and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global regenerative medicine market, estimated market shares, and company profiles for the leading players.
  • Key Mergers And Acquisitions - This chapter gives information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for regenerative medicine providers in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS (North American Industry Classification System) codes covered, abbreviations, and currencies codes used in this report.

Markets Covered:


  1. By Product: Cell Based; Gene Based; Tissue Based
  2. By End-Use: Ambulatory Surgical Centers; Hospitals And Clinics; Others
  3. By Application: Musculoskeletal; Oncology; Dental; Wound Care; Others

Companies Mentioned:

Smith & Nephew plc; Integra LifeSciences; Stryker Corporation; MiMedx Group, Inc.; Zimmer Biomet Holdings Inc.


Countries:

China, Japan, India, Australia, USA, Brazil, UK, Germany, France, Spain, Italy, Russia, South Korea, Singapore, Thailand, Indonesia, Vietnam, Philippines, Malaysia, New Zealand, Hong Kong, Belgium, Sweden, Austria, Denmark, Netherlands, Norway, Finland, Portugal, Switzerland, Ireland, Poland, Czech Republic, Romania, Canada, Mexico, Argentina, Peru, Venezuela, Colombia, Chile, Saudi Arabia, Turkey, UAE, Israel, South Africa, Egypt, Nigeria


Regions:

Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa


Time series:

Five years historic and ten years forecast.


Data:

Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; regenerative medicine indicators comparison.


Data segmentations:

country and regional historic and forecast data; market share of competitors; market segments.


Sourcing and Referencing:

Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Smith & Nephew plc
  • Integra LifeSciences
  • Stryker Corporation
  • MiMedx Group, Inc.
  • Zimmer Biomet Holdings Inc.

Methodology

Loading
LOADING...